These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3050220)

  • 1. [Effect of intensive treatment on diabetic retinopathy].
    Hanssen KF; Brinchmann-Hansen O; Dahl-Jørgensen K; Sandvik L
    Journ Annu Diabetol Hotel Dieu; 1988; ():167-73. PubMed ID: 3050220
    [No Abstract]   [Full Text] [Related]  

  • 2. Tight glycemic control? Negative.
    Raskin P
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():21-4; discussion 24-5. PubMed ID: 1347535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is tight blood sugar control effective and justified? Affirmative.
    Skyler JS
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():17-20; discussion 24-5. PubMed ID: 1347534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Type 1 diabetes: long-term effects of intensive insulin therapy on diabetic retinopathy and nephropathy].
    Letonturier P
    Presse Med; 2000 Mar; 29(11):598. PubMed ID: 10776417
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of good blood sugar control in diabetic retinopathy].
    Kohner EM
    Journ Annu Diabetol Hotel Dieu; 1984; ():327-32. PubMed ID: 6399536
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetic retinopathy after one year of improved metabolic control obtained by continuous subcutaneous insulin infusion (CSII).
    Olsen T; Ehlers N; Nielsen CB; Beck-Nielsen H
    Acta Ophthalmol (Copenh); 1985 Jun; 63(3):315-9. PubMed ID: 4036563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycemic control on microvascular complications in patients with type I diabetes mellitus.
    Rosenstock J; Friberg T; Raskin P
    Am J Med; 1986 Dec; 81(6):1012-8. PubMed ID: 3541587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of blood glucose control and retinopathy during long-term treatment of insulin-dependent diabetes mellitus with intraperitoneal infusion of insulin].
    Jaffiol C; Jacques-Apostol D; Renard E; Millet P; Compeyre S; Lauton D; Picot MC; Bringer J
    Bull Acad Natl Med; 1996 Jan; 180(1):177-91; discussion 191-4. PubMed ID: 8696875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes and the insulin pump: functional results after 5 consecutive years of permanent use].
    Mirouze J; Rouault R; Misse P; Millet P; Bordat B; Selam JL; Boudet C
    Bull Soc Ophtalmol Fr; 1989 Mar; 89(3):437-40. PubMed ID: 2598391
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of strict control on diabetic complications.
    Hanssen KF; Dahl-Jørgensen K; Brinchmann-Hansen O
    Acta Endocrinol Suppl (Copenh); 1985; 272():57-60. PubMed ID: 3914805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes in the young: from Leicester to Siena (via Oslo, Bethesda and Hvidore).
    Swift PG
    Acta Biomed; 2005; 76 Suppl 3():7-13. PubMed ID: 16915789
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
    ; Nathan DM; Genuth S; Lachin J; Cleary P; Crofford O; Davis M; Rand L; Siebert C
    N Engl J Med; 1993 Sep; 329(14):977-86. PubMed ID: 8366922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diabetes Control and Complications Trial: new challenges for the primary physician.
    Clarke WL
    Va Med Q; 1994; 121(3):185-8. PubMed ID: 8061070
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous glucose monitoring used with an insulin pump: should we recommend it to people with diabetes and can we afford it?
    Hitman GA
    Diabet Med; 2015 May; 32(5):571. PubMed ID: 25892446
    [No Abstract]   [Full Text] [Related]  

  • 15. Normoglycaemic re-entry and diabetic complications.
    Keen H
    Diabet Med; 1984 Jul; 1(2):85-7. PubMed ID: 6242792
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of emerging new technologies.
    Garg SK
    Diabetes Technol Ther; 2008 Oct; 10(5):413-4. PubMed ID: 18715219
    [No Abstract]   [Full Text] [Related]  

  • 17. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII).
    Olsen T; Richelsen B; Ehlers N; Beck-Nielsen H
    Acta Ophthalmol (Copenh); 1987 Apr; 65(2):185-9. PubMed ID: 3300140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic control in labile type I diabetes with conventional insulin therapy, basal bolus insulin therapy using pens and continuous subcutaneous insulin infusion with the pump].
    Biesenbach G; Grafinger P; Kaiser W; Stuby U; Zazgornik J
    Med Klin (Munich); 1988 May; 83(12):398-401. PubMed ID: 3043159
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risk factors for the development of diabetic retinopathy in patients with insulin-dependent diabetes mellitus treated with continuous subcutaneous insulin infusion].
    Austenat E
    Wien Med Wochenschr; 1992; 142(13):277-80. PubMed ID: 1413821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.